Publicaciones en colaboración con investigadores/as de Harvard Medical School (8)

2022

  1. A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas

    CANCER RESEARCH COMMUNICATIONS, Vol. 2, Núm. 11, pp. 1326-1333

2017

  1. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy-Biotherapy and Novel Targeted Agents

    Neuroendocrinology

  2. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy-Chemotherapy

    Neuroendocrinology

2004

  1. A phase I trial of daily oral 4′-N-benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignancies

    Investigational New Drugs

2003

  1. A phase I study of 9-Nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors

    Cancer, Vol. 97, Núm. 1, pp. 148-154

2002

  1. A phase II and pharmacokinetic study of ecteinascidin 743 in patients with gastrointestinal stromal tumors

    Oncologist, Vol. 7, Núm. 6, pp. 531-538

  2. Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily

    Journal of Clinical Oncology, Vol. 20, Núm. 18, pp. 3772-3784

2000

  1. High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - A phase II study

    Bone Marrow Transplantation, Vol. 25, Núm. 1, pp. 19-24